Aura Biosciences, Inc.
AURA
$7.64
-$0.01-0.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 323.84M | 114.73M | 144.24M | 161.87M | 177.31M |
| Total Receivables | 1.76M | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 651.00K | 1.16M | 1.67M | 2.15M | 648.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.77M | 2.61M | 3.83M | 6.10M | 6.00M |
| Total Current Assets | 329.03M | 118.50M | 149.74M | 170.12M | 183.96M |
|
|
|||||
| Total Current Assets | 329.03M | 118.50M | 149.74M | 170.12M | 183.96M |
| Net Property, Plant & Equipment | 17.19M | 17.89M | 18.45M | 18.86M | 19.49M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.91M | 1.29M | 1.24M | 1.05M | 953.00K |
| Total Assets | 348.13M | 137.68M | 169.43M | 190.02M | 204.40M |
|
|
|||||
| Total Accounts Payable | 2.25M | 2.57M | 1.55M | 1.89M | 1.29M |
| Total Accrued Expenses | 13.11M | 10.49M | 13.35M | 13.56M | 10.14M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.29M | 3.27M | 3.24M | 3.22M | 3.20M |
| Total Finance Division Other Current Liabilities | 908.00K | 378.00K | 242.00K | 152.00K | 227.00K |
| Total Other Current Liabilities | 908.00K | 378.00K | 242.00K | 152.00K | 227.00K |
| Total Current Liabilities | 19.56M | 16.71M | 18.38M | 18.82M | 14.85M |
|
|
|||||
| Total Current Liabilities | 19.56M | 16.71M | 18.38M | 18.82M | 14.85M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 13.30M | 13.72M | 14.13M | 14.53M | 14.92M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 32.86M | 30.43M | 32.52M | 33.36M | 29.77M |
|
|
|||||
| Common Stock & APIC | 914.77M | 621.56M | 617.43M | 611.46M | 603.33M |
| Retained Earnings | -559.74M | -514.10M | -480.42M | -454.86M | -428.73M |
| Treasury Stock & Other | -39.76M | -207.00K | -102.00K | 69.00K | 25.00K |
| Total Common Equity | 315.27M | 107.25M | 136.91M | 156.67M | 174.63M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 315.27M | 107.25M | 136.91M | 156.67M | 174.63M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 315.27M | 107.25M | 136.91M | 156.67M | 174.63M |
|
|
|||||